Merck, Ridgeback Biotherapeutics withdraw COVID pill Molnupiravir application in EU Ruchika Sharma30 Jun 2023 10:00 AM ISTMerck and Co and partner Ridgeback Biotherapeutics said on Tuesday they had withdrawn their COVID-19 pill application in the European Union,...
EU drug regulator advices against market nod for Merck COVID pill Lagevrio for adults Ruchika Sharma26 Feb 2023 3:45 PM ISTUS: The European Union's drug regulator said on Friday its Committee for Medicinal Products for Human Use has advised against market authorisation of...
Merck expects 2022 sales up nearly 20 percent, mostly on molnupiravir Ruchika Sharma6 Feb 2022 9:00 AM ISTNew Delhi: Merck & Co said on Thursday it expects its 2022 sales to increase as much as 18 percent over last year, mostly on sales of its new...
Belgium to buy courses of Pfizer, Merck COVID pills Ruchika Sharma3 Jan 2022 9:00 AM ISTBrussels: Belgium has agreed to buy 10,000 courses each of the COVID-19 antiviral oral treatments developed by Pfizer and Merck & CO, a...
Merck, Ridgeback Molnupiravir gets special approval for emergency in Japan Ruchika Sharma25 Dec 2021 2:46 PM ISTKenilworth: Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics have announced that Japan's Ministry of Health,...
Molnupiravir bags USFDA nod Dr. Nandita Mohan24 Dec 2021 6:30 PM ISTMerck and Ridgeback Biotherapeutics have announced that the U.S. Food and Drug Administration (USFDA) has granted Emergency Use Authorization (EUA)...
Health Bulletin 24/December/2021 Roshni Dhar24 Dec 2021 6:00 PM ISTHere are Top Health stories of the dayDoctors Indemnity Not For Hospital: Supreme CourtThe Supreme Court has recently observed that if a hospital is...
Finally Molnupiravir gets USFDA nod Ruchika Sharma24 Dec 2021 11:36 AM ISTKenilworth: A day after Pfizer's Paxlovid bagged the U.S. Food and Drug Administration (USFDA) Emergency Use Authorization (EUA) nod, Merck's...
Narrow Vote but Merck's molnupiravir gets USFDA expert panel Yes Ruchika Sharma1 Dec 2021 12:08 PM ISTThe vote was 13 for and 10 against authorization
Covid-19: Merck Molnupiravir significantly less effective in new analysis Ruchika Sharma29 Nov 2021 11:00 AM ISTNew Delhi: Merck & Co said on Friday updated data from its study of its experimental COVID-19 pill showed the drug was significantly less...
Merck Molnupiravir under review amid rising COVID cases, new variant in US MD Bureau27 Nov 2021 11:26 AM ISTNew York: US health regulators are expected to make public a staff review about the Covid-19 pill molnupiravir from Merck and Co and Ridgeback...
Merck seeks EMA to authorize Covid-19 pill Molnupiravir Hina Zahid25 Nov 2021 10:00 AM ISTNew Delhi: The European Medicines Agency said it has received a request from Merck to authorise its coronavirus antiviral, the first pill shown to...
